Intuitive Surgical (ISRG) reported robust second-quarter 2026 financial results, driven by significant growth in both its core da Vinci and newer Ion robotic surgery platforms. Total revenue reached $2.89 billion, representing a 19% year-over-year increase from the prior year's $2.44 billion. This expansion was fueled...
Intuitive Surgical announced its first quarter 2026 financial results today, reporting significant growth across its global portfolio of robotic-assisted surgery technologies. Worldwide procedures combining both da Vinci and Ion systems grew approximately 17% compared to the first quarter of 2025. The company placed 431 da...
Intuitive Surgical (ISRG) shares fell 37% to $355 following Q2 earnings, where the company beat revenue estimates with 19% growth and non-GAAP EPS of $2.80. Despite the financial beat, management cut full-year procedure growth guidance for the da Vinci system to a range of 13.5%-15.5%,...
Intuitive Surgical (ISRG) reported standout Q1 2023 results, beating analyst estimates with revenue of $1.70 billion, a 14% year-over-year increase, and adjusted earnings of $1.23 per share versus the expected $1.20. The surge was driven by a 26% jump in procedure volumes as hospitals cleared...
Intuitive Surgical reported its Q1 earnings with a notably upbeat tone, driven by strong revenue growth of 23% year over year to $2.77 billion. Recurring revenue increased 23% to $2.4 billion, now representing 86% of total sales, which underscores the company's annuity-like business model favored...
Intuitive Surgical (ISRG) saw its stock rise approximately 7% in intraday trading following the release of better-than-expected Q1 earnings results, with revenue increasing by roughly 23% year-over-year and non-GAAP net income climbing around 36% year-over-year. The company's performance exceeded consensus estimates, prompting Wall Street analysts...
Intuitive Surgical (ISRG) is preparing to release its Q2 2026 earnings results after market close on Thursday, July 16th. Analysts project the company will report earnings per share of $2.48 and revenue of $2.8249 billion for the quarter. The upcoming earnings call is scheduled for...
Intuitive Surgical (ISRG), Medtronic (MDT), and Stryker (SYK) are identified as key players where surgical robotics integrates with artificial intelligence capabilities. Intuitive Surgical reported Q1 FY26 non-GAAP EPS of $2.50, beating estimates by 18.66%, with revenue reaching $2.77 billion. The company's installed base of da...
Intuitive Surgical (ISRG) stock surged 7.2% on Wednesday to close at $483.62 after the company reported stronger-than-expected first-quarter results and raised its full-year procedural outlook. The medical technology giant beat estimates with quarterly sales growing 23% year-over-year to $2.77 billion, compared to analyst expectations of...
HSBC downgraded Intuitive Surgical (NASDAQ:ISRG) from a Buy to a Hold rating, setting a $391 target price. This move follows a series of recent analyst adjustments, including Sanford Bernstein lowering its target to $685 and Jefferies reducing its objective to $515, though the consensus remains...
Intuitive Surgical (NASDAQ:ISRG) saw a mixed institutional landscape in the first quarter, highlighted by ABN AMRO Bank N.V. reducing its stake by 37.1% to 40,572 shares, worth approximately $18.9 million. Conversely, several smaller hedge funds including Riversedge Advisors LLC and Fiduciary Financial Group LLC increased...
Intuitive Surgical (ISRG) reported a record first quarter with revenue climbing 23% to $2.77 billion and earnings per share of $2.50, significantly beating the analyst consensus of $2.08. Despite these strong fundamentals, shares dropped approximately 25% since the start of the year, trading around EUR...
Alamar Capital Management LLC acquired a new stake in Intuitive Surgical, Inc. (ISRG) during the first quarter, purchasing 3,563 shares valued at approximately $1.64 million. This filing highlights continued institutional interest alongside other funds like Fiduciary Financial Group and North Star Investment Management, which increased...
Shares of Intuitive Surgical (NASDAQ:ISRG) hit a new 52-week low around $346 on Monday, driven by JPMorgan Chase lowering its price target from $550 to $450 while maintaining an overweight rating. The stock has faced mixed analyst sentiment recently, with Deutsche Bank cutting its target...
Intuitive Surgical (NASDAQ:ISRG) faces a mixed analyst outlook following a cluster of price target reductions from major brokerages on Friday. Citigroup lowered its target from $590 to $500, while BTIG Research, Robert W. Baird, and Sanford C. Bernstein also cut their targets to $469, $500,...
Aaron Wealth Advisors LLC reduced its stake in Intuitive Surgical, Inc. (ISRG) by 21.9% in the first quarter, selling 1,377 shares and holding a remaining position of 4,903 shares valued at $2.26 million. This move was part of broader institutional activity where other firms like...
Fisher Funds Management LTD significantly increased its position in Intuitive Surgical (ISRG) by 28.3% in the first quarter, acquiring an additional 31,392 shares to hold a total of 142,156 shares valued at approximately $65.5 million. This move makes ISRG the fund's 10th largest holding, representing...
Intuitive Surgical (ISRG) is highlighted as potentially undervalued following Q1 2026 data showing strong demand for its da Vinci 5 robotic surgery systems. The company placed 431 units in the quarter, representing a 17% year-over-year increase, driven by an upgrade cycle and higher leasing activity...
Intuitive Surgical (NASDAQ: ISRG) stock is currently trading near its 52-week lows, having declined approximately 30% from its early 2025 highs. Despite this drawdown, Wall Street analysts maintain an upbeat outlook with an average price target of $570, suggesting a potential recovery and gain of...
Intuitive Surgical (ISRG) reported strong Q1 2026 non-GAAP earnings, posting EPS of $2.50 against a consensus of $2.11, while revenue reached $2.77 billion, representing a 23% year-over-year increase. The company successfully placed 431 new da Vinci robotic systems during the quarter, including 232 units of...
